Performance of UTHR United Therapeutics | 12.8% in 12m
Compare UTHR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare United Therapeutics with its related Sector/Index XBI
Performance Duell UTHR vs XBI
| TimeFrame | UTHR | XBI |
|---|---|---|
| 1 Day | 1.17% | 1.16% |
| 1 Week | 9.40% | 7.44% |
| 1 Month | 12.9% | -2.58% |
| 3 Months | 21.0% | 0.42% |
| 6 Months | 13.1% | 29.44% |
| 12 Months | 12.8% | 10.82% |
| YTD | 13.5% | -2.09% |
| Rel. Perf. 1m | 1.38 | |
| Rel. Perf. 3m | -0.16 | |
| Rel. Perf. 6m | -1.57 | |
| Rel. Perf. 12m | 0.53 |
Is United Therapeutics a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, United Therapeutics (NASDAQ:UTHR) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 70.80 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTHR as of May 2024 is 264.60. This means that UTHR is currently overvalued and has a potential downside of 2.51% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTHR as of May 2024 is 264.60. This means that UTHR is currently overvalued and has a potential downside of 2.51% (Sold with Premium).
Is UTHR a buy, sell or hold?
- Strong Buy: 9
- Buy: 4
- Hold: 3
- Sell: 1
- Strong Sell: 0
Values above 0%: UTHR is performing better - Values below 0%: UTHR is underperforming
Compare UTHR with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.09% | 15.59% | -4.95% | -11.89% |
| US NASDAQ 100 | QQQ | 8.82% | 16.15% | -4.78% | -21.74% |
| US Dow Jones Industrial 30 | DIA | 9.06% | 15.28% | -0.88% | -2.84% |
| German DAX 40 | DBXD | 9.59% | 15.21% | -4.72% | -0.32% |
| UK FTSE 100 | ISFU | 8.12% | 10.21% | -1.42% | 3.27% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.47% | 9.58% | 8.50% | 22.77% |
| Hongkong Hang Seng | HSI | 2.53% | 6.73% | 12.63% | 27.29% |
| Japan Nikkei 225 | EXX7 | 7.04% | 18.29% | -0.74% | -6.98% |
| India NIFTY 50 | INDA | 8.08% | 10.20% | -7.75% | -16.46% |
| Brasil Bovespa | EWZ | 6.25% | 13.65% | 8.80% | -10.56% |
UTHR United Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.59% | 16.33% | -6.77% | -23.47% |
| Consumer Discretionary | XLY | 8.03% | 14.66% | 0.84% | -8.70% |
| Consumer Staples | XLP | 9.53% | 12.55% | 1.31% | 12.08% |
| Energy | XLE | 13.61% | 16.95% | 5.54% | -6.12% |
| Financial | XLF | 10.43% | 15.83% | -9.28% | -14.56% |
| Health Care | XLV | 9.00% | 15.50% | 1.43% | 5.98% |
| Industrial | XLI | 9.84% | 14.93% | -8.97% | -11.78% |
| Materials | XLB | 9.78% | 16.94% | -2.34% | -0.63% |
| Real Estate | XLRE | 8.58% | 17.30% | 4.17% | 9.34% |
| Technology | XLK | 9.67% | 17.66% | -3.23% | -20.06% |
| Utilities | XLU | 7.98% | 9.09% | 0.81% | 9.97% |
| Aerospace & Defense | XAR | 6.57% | 11.91% | -2.62% | -8.26% |
| Biotech | XBI | 1.96% | 15.51% | -16.31% | 2.00% |
| Homebuilder | XHB | 8.37% | 16.94% | -24.63% | -35.68% |
| Retail | XRT | 9.01% | 17.86% | -7.82% | -8.19% |
Does United Therapeutics outperform its market, is UTHR a Sector Leader?
Yes, over the last 12 months United Therapeutics (UTHR) made 12.82%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months UTHR made 20.95%, while XBI made 0.42%.
Yes, over the last 12 months United Therapeutics (UTHR) made 12.82%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months UTHR made 20.95%, while XBI made 0.42%.
| Period | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 12.93% | -2.58% | -2.66% |
| 3 Months | 20.95% | 0.42% | 2.48% |
| 12 Months | 12.82% | 10.82% | 24.71% |